Related Experiment Video
Updated: Aug 13, 2025

08:17
Optical Coherence Tomography: Imaging Mouse Retinal Ganglion Cells In Vivo
Published on: September 22, 2017
19.4K
OPA1 Dominant Optic Atrophy: Diagnostic Approach in the Pediatric Population
Natalia Arruti1,2, Patricia Rodríguez-Solana3, María Nieves-Moreno1,2
1Department of Pediatric Ophthalmology, IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain.
Current Issues in Molecular Biology
|January 20, 2023
Summary
This study investigated optic atrophy 1 (OPA1) mutations in pediatric patients, finding a genotype-phenotype correlation. Early diagnosis of dominant optic atrophy is crucial for genetic counseling and avoiding unnecessary treatments.
Area of Science:
- Ophthalmology
- Genetics
- Pediatric Medicine
Background:
- Dominant optic atrophy is a hereditary condition affecting the optic nerve.
- Optic atrophy 1 (OPA1) gene mutations are a known cause of dominant optic atrophy.
- Understanding genotype-phenotype correlations is essential for accurate diagnosis and management.
Purpose of the Study:
- To investigate the genotype-phenotype correlation in pediatric patients with OPA1 mutations.
- To analyze clinical and genetic data within and between families.
- To identify novel OPA1 mutations.
Main Methods:
- Clinical examination of pediatric patients and relatives.
- Genetic sequencing of the OPA1 gene.
- Optical coherence tomography (OCT) for retinal layer thickness measurements.
- Visual acuity and visual field testing.
Main Results:
- Eleven pediatric patients with confirmed OPA1 mutations were studied.
- Reduced visual acuity and centrocecal scotoma were common findings.
- Seven different OPA1 mutations were identified, including one novel mutation (NM_130837.3: c.1406_1407del).
- Retinal nerve fiber layer, ganglion cell layer, and macular thickness were measured via OCT.
Conclusions:
- A genotype-phenotype correlation exists for OPA1 mutations.
- Early diagnosis of dominant optic atrophy is critical for patient management and genetic counseling.
- Identification of novel mutations expands the understanding of OPA1-related optic neuropathies.
Related Concept Videos
Open Angle Glaucoma: Treatment
516
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
516
Glaucoma: Overview
674
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
674
Angle Closure Glaucoma: Treatment
608
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
608

